A Novel Relay Method for Determining Low-Clearance Values
- 1 September 2012
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 40 (9) , 1860-1865
Abstract
A novel relay method has been developed using cryopreserved human hepatocytes to measure intrinsic clearance of low-clearance compounds. The relay method involved transferring the supernatant from hepatocyte incubations to freshly thawed hepatocytes at the end of the 4-h incubation to prolong the exposure time to active enzymes in hepatocytes. An accumulative incubation time of 20 h or longer in hepatoctyes can be achieved using the method. The relay method was validated using seven commercial drugs (diazepam, disopyramide, theophylline, timolol, tolbutamide, S-warfarin, and zolmitriptan) that were metabolized by various cytochrome P450s with low human in vivo intrinsic clearance at approximately 2 to 15 ml · min−1 · kg−1. The results showed that the relay method produced excellent predictions of human in vivo clearance. The difference between in vitro and in vivo intrinsic clearance was within 2-fold for most compounds, which is similar to the standard prediction accuracy for moderate to high clearance compounds using hepatocytes. The relay method is a straightforward, relatively low cost, and easy-to-use new tool to address the challenges of low clearance in drug discovery and development.Keywords
This publication has 18 references indexed in Scilit:
- Identification of the Rate-Determining Process in the Hepatic Clearance of Atorvastatin in a Clinical Cassette Microdosing StudyClinical Pharmacology & Therapeutics, 2011
- Prediction of Human Metabolic Clearance from In Vitro Systems: Retrospective Analysis and Prospective ViewPharmaceutical Research, 2010
- Drug-Like Property Concepts in Pharmaceutical DesignCurrent Pharmaceutical Design, 2009
- Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction ApproachesThe Journal of Clinical Pharmacology, 2009
- Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver MicrosomesDrug Metabolism and Disposition, 2009
- High Throughput ADME Screening: Practical Considerations, Impact on the Portfolio and Enabler of In Silico ADME ModelsCurrent Drug Metabolism, 2008
- Applications of High Throughput Microsomal Stability Assay in Drug DiscoveryCombinatorial Chemistry & High Throughput Screening, 2008
- Toxicity2008
- Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic ClearanceDrug Metabolism and Disposition, 2007
- Profiling drug-like properties in discovery researchCurrent Opinion in Chemical Biology, 2003